Pharmaco-metabolomics

Pharmaco-metabolomics used to determine the metabolic biomarkers that could potentially predict different responses of clinical drugs by identifying differential metabolites at baseline and correlating their variations with the therapeutic outcomes. Presently, Pharmaco-metabolomics remains in its infancy because most pharmaco-metabolomics studies are merely focused on revealing the correlation between baseline metabotypes which are influenced by factors like-gut, ages, drug intake and diets microbiota with drug responses or disease susceptibility to review and decrease the metabolic bases.

 

    Related Conference of Pharmaco-metabolomics

    March 15-16, 2021

    12th Tissue Repair and Regeneration Congress

    Dubai, UAE
    July 30-30, 2021

    Glycobiology Biochem Conference 2021

    London, UK
    September 06-06, 2021

    27th Asia Pacific Biotechnology Congress

    London, UK
    September 10-10, 2021

    5th International Conference on Protein Engineering

    London, UK
    September 13-14, 2021

    17th World Congress on Structural Biology

    Prague, Czech Republic
    September 27-28, 2021

    25th European Biotechnology Congress

    Dublin, Ireland
    November 08-09, 2021

    23rd Global Biotechnology Congress

    Singapore City, Singapore
    November 18-19, 2021

    25th World Congress on Pharmaceutical Biotechnology

    Barcelona, Spain
    December 01-02, 2021

    18th International Conference on Metabolomics and Proteomics

    Frankfurt, Germany
    December 08-09, 2021

    World Congress on Biosensors and Bioelectronics

    London, UK
    February 25-26, 2022

    International Conference on Biotechnology

    Singapore, Singapore
    August 22-23, 2021

    15thInternational Conference on Proteomics, Genomics & Bioinformatics

    Singapore City, Singapore

    Pharmaco-metabolomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in